- Home
- NRXS vs DTF Comparison
NRXS vs DTF Comparison
Compare NRXS & DTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | NRXS | DTF |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Investment Managers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.9M | 80.0M |
| IPO Year | 2023 | 1995 |
Fundamental Metrics
Financial Performance| Metric | NRXS | DTF |
|---|---|---|
| Price | $6.80 | $11.48 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | ★ 65.7K | 5.0K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,569,282.00 | N/A |
| Revenue This Year | $172.91 | N/A |
| Revenue Next Year | $115.71 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 32.89 | N/A |
| 52 Week Low | $2.20 | $11.18 |
| 52 Week High | $9.33 | $11.61 |
Technical Indicators
Market Signals| Indicator | NRXS | DTF |
|---|---|---|
| Relative Strength Index (RSI) | 45.31 | 48.32 |
| Support Level | $6.60 | $11.44 |
| Resistance Level | $7.63 | $11.56 |
| Average True Range (ATR) | 0.33 | 0.03 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 26.01 | 28.57 |
Price Performance
Historical ComparisonAbout NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
About DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing mainly in a diversified portfolio of investment-grade tax-exempt obligations.